Rituximab, anti-CD20, induces in vivo cytokine release but does not impair ex vivo T-cell responses.
Am J Transplant. 2004 Aug;4(8):1357-60. doi: 10.1111/j.1600-6143.2004.00502.x.
Am J Transplant. 2004.
PMID: 15268740
Free article.
Clinical Trial.